In the combined multicentric cohort, high ASPM expression was significantly associated with a higher grade, higher NPI score, ER negativity, PR negativity, HER2 positive status, P53 mutated types, and basal BC subtypes (Supplementary Figures S2–S5). This evidence concerns the gene ERBB2 and breast cancer.